<DOC>
	<DOCNO>NCT02917135</DOCNO>
	<brief_summary>This post-market , observational , retrospective multi-center Registry design gather information performance Angel® Catheter general clinical practice .</brief_summary>
	<brief_title>Angel® Catheter Post Market Registry</brief_title>
	<detailed_description>The Registry population include consecutive patient Angel® Catheter place participate site . Information use catheter collect placement three day device removal , death discharge , whichever occur first . Date discharge/transfer Critical Care Unit also collect , complete define registry observation . Information 2,000 patient abstracted patient chart review . Sites ask record data Angel® Catheter placement institution start first Angel® Catheter placement training BiO2 Medical , Inc. personnel necessary institutional approval obtain confirm Informed Consent require patient LAR collect , use , publish patient data registry . The registry population include consecutive patient Angel® Catheter place , attempt place , select Registry site . The Instructions Use ( IFU ) Angel® Catheter include follow indication : - Pulmonary thromboembolism anticoagulant contraindicate ; - Failure anticoagulant therapy thromboembolic disease ; - Emergency treatment follow massive pulmonary embolism anticipate benefit conventional therapy reduce ; - Critically ill patient high risk pulmonary embolism , receive medical thromboprophylaxis due either increase risk bleeding , active bleeding heparin induce thrombocytopenia . Since Angel® Catheter indicate use pregnant patient , patient pregnant may include Registry proper risk benefit assess physician . In summary , Registry Event Schedule data collection include follow : - Demographics Current Medical Condition : Information collect include demographic , medical condition indication/s use Angel® Catheter record patient chart . - Device Placement : Placement procedure data collect . If catheter place reason , follow information collect patient . - Angel® Catheter Indwelling experience : While Angel® Catheter place patient 's hospital stay , information regard anticoagulation use ( eCRF form # 9 ) , complication , clinically significant PE , low extremity DVT collect three day device retrieval , discharge hospital , death , whichever occur first . - Device Retrieval : Information ease catheter retrieval key aspect collect . - Registry Exit : Information patient 's status three day post device removal , death , discharge hospital , whichever occur first collect . The patient 's date discharge/transfer Critical Care Unit also collect . - Anticoagulation Therapy : Information use anticoagulation throughout patient 's observation period collect .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>All consecutive patient Angel® Catheter place , attempt place .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>